Bioceramic Textile Composition for Infrared Microcirculation Regulation

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Current treatments for poor blood circulation, such as varicose veins and cellulite, lack effective methods to reach microcirculation and provide sustained therapeutic benefits, with existing infrared radiation therapies not adequately addressing the issue of blood microcirculation regulation.

Innovation Solution

A textile product containing bioceramic microparticles embedded in fibers that emit infrared radiation in the 3 μm to 14.8 μm range, preferentially at 14.8 μm, to regulate blood microcirculation by enhancing infrared reflectivity and reducing emissivity, thereby improving metabolic function and reducing disorders associated with poor circulation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If traditional medical treatments and infrared therapies are used, then general circulation may be improved, but microcirculation regulation is not effectively achieved

Engineering Contradiction:

Improvemicrocirculation regulation effectivenessVSAvoidtreatment efficacy

Core Design Contradiction:

ReliabilityVSProductivity

Solution Approach 1:

The patent changes the physical parameters of infrared radiation by using bioceramic microparticles with specific emissivity characteristics (peak emission at 14.8 μm) to match the absorption spectrum of hemoglobin. This parameter matching enables selective heating of blood vessels and effective microcirculation regulation that traditional infrared sources cannot achieve.

Inventive Principle:

Principle #35Parameter changes

Solution Approach 2:

The patent employs composite materials consisting of bioceramic microparticles embedded in a textile matrix. The bioceramic component provides selective infrared emission at 14.8 μm, while the textile substrate provides mechanical support and skin contact, creating a functional composite that delivers targeted thermal therapy to microcirculation systems.

Inventive Principle:

Principle #40Composite materials

2Reliability

If infrared radiation therapy is applied, then blood circulation may be stimulated, but sustained therapeutic benefits are not maintained

Engineering Contradiction:

Improvetherapeutic benefit sustainabilityVSAvoidtreatment duration

Core Design Contradiction:

ReliabilityVSDuration of action of moving object

Solution Approach 1:

The patent enables continuous therapeutic action by embedding bioceramic microparticles directly into wearable textile products that maintain constant contact with the skin. This allows sustained infrared radiation delivery over extended periods, maintaining continuous microcirculation stimulation and producing lasting therapeutic effects without requiring repeated intensive treatment sessions.

Inventive Principle:

Principle #20Continuity of useful action

3Reliability

If bioceramic microparticles are embedded in textile fibers, then infrared reflectivity is enhanced and emissivity reduced, but manufacturing complexity increases

Engineering Contradiction:

Improveinfrared radiation controlVSAvoidtextile manufacturing complexity

Core Design Contradiction:

ReliabilityVSDevice complexity

Solution Approach 1:

The patent utilizes the porous structure of bioceramic microparticles to maximize surface area for infrared emission while minimizing material usage. The microparticle morphology provides high emissivity control without requiring thick layers or complex multilayer structures, simplifying the embedding process into textile fibers while maintaining optimal infrared radiation control.

Inventive Principle:

Principle #31Porous materials

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The textile product effectively stabilizes and regulates blood microcirculation, as demonstrated by increased infrared reflectivity and reduced emissivity, leading to improved skin health and reduced symptoms of cellulite and varicose veins, with significant improvements observed in clinical trials.

Implementation Method 1

bioceramic microparticles with high capacity of infrared irradiation which, in contact with the heat of the human body is capable of transmitting infrared radiation in the range between 3 μm and 14.8 μm

Methodology Applied

Scientific EffectInfrared radiation: Infrared Radiation

Implementation Method 2

increased infrared reflectivity

Methodology Applied

Scientific EffectInfrared reflectivity: Reflection

Implementation Method 3

reduced emissivity

Methodology Applied

Scientific EffectEmissivity reduction: Thermal Radiation

Data Source

PatentUS8968819B2Textile product

Publication Date: 2015.03.03 HIRATA

AI summary

Improvements applied to a textile product, and more particularly wherein the improved product is a woven textile product—fabric containing bioceramic microparticles embedded into the fibers thereof with high capacity of irradiation in the infrared region, provided to be used both in humans and animals, more particularly the invention is related to a textile product containing bioceramic microparticles with high capacity of infrared irradiation which, in contact with the heat of the human body, is capable of transmitting infrared radiation in the range between 3 μm and 14.8 μm, preferentially in the 14.8 micron range, said infrared radiation at this wavelength being capable of regulating the blood microcirculation, as the result of its high protection, the blood microcirculation being the nervous center of human and/or animal metabolism.